Seeking Alpha

Amarin (AMRN) gets FDA approval of Vascepa, formerly known as AMR101, as an adjunct to diet to...

Amarin (AMRN) gets FDA approval of Vascepa, formerly known as AMR101, as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. Shares are currently halted.
Comments (3)
  • i am so so hapy.and i hope for all the investor who was belive in this drug
    to have avery good business days.
    27 Jul 2012, 07:15 AM Reply Like
  • Why is AMRN price dropping?
    27 Jul 2012, 10:52 AM Reply Like
  • Simple... the market's are rigged to force people lose their money.
    This is exactly why I never bought AMRN over $11. Too much risk.
    27 Jul 2012, 12:43 PM Reply Like
DJIA (DIA) S&P 500 (SPY)